Evidence map›Paper›PMID 39702320›Full record

ArticleCancer & metabolism2024

A whole food, plant-based diet reduces amino acid levels in patients with metastatic breast cancer.

TashJaé Q Scales, Bradley Smith, Lisa M Blanchard, Nellie Wixom, Emily T Tuttle, Brian J Altman, Luke J Peppone, Joshua Munger, Thomas M Campbell, Erin K Campbell and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Cancer & metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03045289 (Whole-Food, Plant-Based Nutrition Among Women With Metastatic Breast Cancer), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03045289 nacompletednot on this map

Whole-Food, Plant-Based Nutrition Among Women With Metastatic Breast Cancer: A Pilot Study of Recruitment, Retention, and Preliminary Changes in Biomarkers and Symptoms.

TypeinterventionalSponsorUniversity of RochesterRan2018 to 2022Enrolled32ConditionsMetastatic Breast Cancer, Breast Cancer Stage IVArmsPlant-Based Diet
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

TashJaé Q ScalesDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, 14642, USA.
Bradley SmithWilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, 14642, USA.
Lisa M BlanchardDepartment of Family Medicine, University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY, 14642, USA.
Nellie WixomClinical Research Center, University of Rochester Medical Center, Rochester, NY, USA.
Emily T TuttleDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, 14642, USA.
Brian J AltmanDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, 14642, USA.
Luke J PepponeWilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, 14642, USA.
Joshua MungerWilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, 14642, USA.
Thomas M CampbellDepartment of Family Medicine, University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY, 14642, USA.
Erin K CampbellDepartment of Public Health Sciences, University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY, 14642, USA.
Isaac S HarrisDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, 14642, USA. isaac_harris@urmc.rochester.edu.

Funding

Metabolic modulation by the HCMV UL38 geneR01AI150698 · NIAID · UNIVERSITY OF ROCHESTER · PI JOSHUA C MUNGER · 2020 to 2026
$2.4M
Impact of extracellular glutathione catabolism on triple-negative breast cancerR01CA269813 · NCI · UNIVERSITY OF ROCHESTER · PI Jeevisha Bajaj · 2022 to 2026
$2.2M
Metabolism and HCMV: determinants of the antiviral stateR01AI181865 · NIAID · UNIVERSITY OF ROCHESTER · PI JOSHUA C MUNGER · 2024 to 2026
$1.8M
American Cancer Society RSG-23-971782-01-TBENCI NIH HHS R01 CA269813NCI NIH HHS R01CA269813NCI NIH HHS R01CA269813-S2NIAID NIH HHS R01 AI150698NIAID NIH HHS R01 AI181865
6 · The paper itself

Abstract

backgroundAmino acids are critical to tumor survival. Tumors can acquire amino acids from the surrounding microenvironment, including the serum. Limiting dietary amino acids is suggested to influence their serum levels. Further, a plant-based diet is reported to contain fewer amino acids than an animal-based diet. The extent to which a plant-based diet lowers the serum levels of amino acids in patients with cancer is unclear.

methodsPatients with metastatic breast cancer (n = 17) were enrolled in a clinical trial with an ad libitum whole food, plant-based diet for 8 weeks without calorie or portion restriction. Dietary changes by participants were monitored using a three-day food record. Serum was collected from participants at baseline and 8 weeks. Food records and serum were analyzed for metabolic changes.

resultsWe found that a whole food, plant-based diet resulted in a lower intake of calories, fat, and amino acids and higher levels of fiber. Additionally, body weight, serum insulin, and IGF were reduced in participants. The diet contained lower levels of essential and non-essential amino acids, except for arginine (glutamine and asparagine were not measured). Importantly, the lowered dietary intake of amino acids translated to reduced serum levels of amino acids in participants (5/9 essential amino acids; 4/11 non-essential amino acids).

conclusionsThese findings provide a tractable approach to limiting amino acid levels in persons with cancer. This data lays a foundation for studying the relationship between amino acids in patients and tumor progression. Further, a whole-food, plant-based diet has the potential to synergize with cancer therapies that exploit metabolic vulnerabilities.

trial registrationThe clinical trial was registered with ClinicalTrials.gov identifier NCT03045289 on 2017-02-07.

Indexed as

Amino acidsCaloriesCancerCarbohydrateDietFatFiberPlant-basedProteinWhole food

Identifiers

PMID39702320
PMCPMC11657127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.